[Control of motor activity in relation to monoaminergic mechanisms].
D000818:Animals; D001921:Brain / Q000378:metabolism*; D002389:Catatonia / Q000139:chemically induced; D002531:Cerebellum / Q000503:physiopathology; D003342:Corpus Striatum / Q000503:physiopathology; D004298:Dopamine / Q000378:metabolism* / Q000502:physiology; D018492:Dopamine Antagonists; D000882:Haplorhini; D006801:Humans; D008636:Mesencephalon / Q000503:physiopathology; D008750:Methyldopa / Q000494:pharmacology; D008781:Methyltyrosines / Q000494:pharmacology; D009043:Motor Activity; D010300:Parkinson Disease / Q000209:etiology / Q000378:metabolism; D010640:Phenothiazines / Q000494:pharmacology; D012012:Red Nucleus / Q000503:physiopathology; D012110:Reserpine / Q000494:pharmacology; D013378:Substantia Nigra / Q000503:physiopathology; D014202:Tremor / Q000139:chemically induced
D018492:Dopamine Antagonists; D008781:Methyltyrosines; D010640:Phenothiazines; D008750:Methyldopa; D012110:Reserpine; D004298:Dopamine
Contrôle de l'activité motrice au regard des mécanismes monoaminergiques.